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Reduced Il17a Expression Distinguishes
a Ly6cloMHCIIhi Macrophage Population
Promoting Wound Healing
Mathieu P. Rodero1, Samantha S. Hodgson1, Brett Hollier2, Christophe Combadiere3,4,5 and
Kiarash Khosrotehrani1
Macrophages are the main components of inflammation during skin wound healing. They are critical in wound
closure and in excessive inflammation, resulting in defective healing observed in chronic wounds. Given the
heterogeneity of macrophage phenotypes and functions, we here hypothesized that different subpopulations of
macrophages would have different and sometimes opposing effects on wound healing. Using multimarker flow
cytometry and RNA expression array analyses on macrophage subpopulations from wound granulation tissue, we
identified a Ly6cloMHCIIhi ‘‘noninflammatory’’ subset that increased both in absolute number and proportion
during normal wound healing and was missing in Ob/Ob and MYD88 / models of delayed healing. We also
identified IL17 as the main cytokine distinguishing this population from proinflammatory macrophages and
demonstrated that inhibition of IL17 by blocking Ab or in IL17A / mice accelerated normal and delayed healing.
These findings dissect the complexity of the role and activity of the macrophages during wound inflammation and
may contribute to the development of therapeutic approaches to restore healing in chronic wounds.
Journal of Investigative Dermatology (2013) 133, 783–792; doi:10.1038/jid.2012.368; published online 13 December 2012
INTRODUCTION
Skin wound healing is a complex multistep process, involving
the proliferation and migration of keratinocytes, recruitment
and differentiation of myofibroblasts, and angiogenesis result-
ing in the restoration of the skin barrier integrity after injury
(Gurtner et al., 2008). However, before these events directly
related to wound closure take place, an inflammatory phase
initiates the formation of the granulation tissue (gt). Various
leukocytes are recruited toward the wound area to modulate
the subsequent activities of keratinocytes, fibroblasts, or
endothelial cells.
The central role of macrophages in wounds has been
proposed for decades on the basis of the ability of these cells
to influence the other cell types involved in the healing (Ross
and Odland, 1968; Leibovich and Ross, 1975; Rodero and
Khosrotehrani, 2011). More recent evidence has further
highlighted their essential role in vivo by using genetically
modified mice, allowing their depletion before or along
the healing (Goren et al., 2009; Lucas et al., 2009; Mirza
et al., 2009). Indeed, macrophage depletion is associated with
defective angiogenesis, defective recruitment or differentiation
of myofibroblasts, reduced collagen deposition, and defective
wound closure. Interestingly, the depletion of macrophages at
different stages of the healing suggested changes of their
activity depending on the healing stage (Lucas et al., 2009).
Macrophages arise from the differentiation of circulating
monocytes upon tissue infiltration. Murine monocytes have
been subdivided into two subpopulations based on their
expression of Ly6c/Gr1: the Ly6chi inflammatory monocytes
and the Ly6clo-resident monocytes (Geissmann et al., 2003).
Macrophage polarization depends on environmental stimuli
including cytokines, Toll-like receptor ligands, or growth
factors (Gordon, 2003). Although this paradigm holds
in vitro, its extrapolation to in vivo macrophages remains
difficult and has seldom been addressed. More specifically,
the existence of functionally different subpopulations among
wound-associated macrophages (WAMs) remains mostly
elusive. More recently, it has been demonstrated that iron-
dependent activation of a macrophage population with an
unrestrained proinflammatory M1 phenotype leads to chronic
inflammation, tissue breakdown, and impaired wound healing
(Sindrilaru et al., 2011), confirming the critical role of
macrophages in determining wound healing outcome and
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suggesting their essential role in the pathogenesis of leg ulcers
related to veinous insufficiency (Goren et al., 2007; Lai et al.,
2009; Sindrilaru et al., 2011).
In the present study, we hypothesized that different sub-
populations of macrophages with different and sometimes
opposing functions could drive wound inflammation or
wound closure during normal and pathological wound heal-
ing. Here we report the kinetics of infiltration of the gt by
macrophages and define important functional populations
associated with normal or pathological healing. Further
characterizing these cells by RNA expression arrays, we report
a Ly6cloMHCIIhi ‘‘noninflammatory’’ macrophage population,
which increases both in absolute number and proportion
during normal wound healing, and is the main defective
population in the gt of two models with delayed wound
healing, the leptin-deficient Ob/Ob (Ansell et al., 2012) mice
and the MYD88 / mice (Macedo et al., 2007). Ob/Ob
mice display excessive wound inflammation and significant
delays in healing time, reflecting events expected in chronic
diabetic wounds. Similarly, MyD88 / mice have a
defective switch from inflammatory to proangiogenic macro-
phages within the gt, resulting in delayed healing (Macedo
et al., 2007). We also identify IL17 as a major cytokine distin-
guishing this population from proinflammatory macrophages.
Finally, using Il17a / mice or blocking IL17ab, we
demonstrate that inhibition of IL17 improved both normal
and delayed healing.
RESULTS
WAMs are mainly Ly6clo and derive essentially from bone
marrow monocytes
The initial step of our project was to understand the phenotype
and kinetics of macrophages recruited during the wound
healing process. We have therefore analyzed mononuclear
cells isolated from bone marrow (BM), spleen, blood, and gt at
different time points during healing in wild-type (WT) adult
mice. In BM, blood, and spleen, monocytes were defined as the
CD11bhiLy6gNK1.1 cells (Supplementary Figure 1 online;
Combadiere et al., 2008). In wound gt, WAMs were defined as
the CD11bhiLy6gloF4/80hi cells (Figure 1a; Supplementary
Figure 2 online). WAMs absolute numbers increased until D2
to reach around 3,000 cells per wound. Their number within
the wound remained stable until D5, and then progressively
decreased returning to steady-state levels by D14 (Figure 1d).
We then looked at Ly6c expression levels by WAMs as this
marker has been extensively used not only in distinguishing
monocyte but also macrophage subpopulations (Geissmann
et al., 2003; Nahrendorf et al., 2007; Cochain et al., 2010;
Figure 1b). At day 1 (D1), 74% (±6) of the WAMs were
Ly6chi, whereas by D2, and until the resorption of the gt, most
WAMs were Ly6clo (Figure 1b). This was suggestive of a
transition between the inflammatory and a tissue formation
phase between D1 and D2 in WT mice.
To further investigate the origin of WAMs, we analyzed
changes upon wounding in monocyte homeostasis in their
classical reservoirs: blood, BM, and spleen (Figure 1d;
Supplementary Figure 3 online). In the blood, we observed a
70% increase in monocyte numbers at D2 returning to a
steady-state level by D4. In the BM, the absolute number of
monocytes decreased by 28% on D1. Only Ly6chi monocyte
numbers decreased, suggesting their egress toward the circu-
lation contributing to the peak of monocytosis as proposed in
other models (Nahrendorf et al., 2007; Cochain et al., 2010).
Finally, the variations observed in the spleen were comparable
to those in blood, suggesting that the early monocytes homing
to the wound originated from the BM rather than the spleen.
However, it remained unclear to what extent skin-resident
macrophages contributed to the WAM populations. To
address this question, we generated BM chimeras by
reconstituting lethally irradiated mice with GFP-expressing
BM. The presence of GFPþ monocyte/macrophages was
investigated in blood, BM, and the gt at D1 after wounding.
Despite a chimerism of 94.1% (±1.4%) in the BM, 30%
(±8.7%) of the WAMs were GFP-negative, suggesting that
local recruitment of radioresistant skin–resident cells repre-
sented a significant proportion of macrophages present in the
wound area at this initial time point (Supplementary Figure 4
online). It is noteworthy that these local macrophages were
expectedly Ly6clo.
Ly6c and major histocompatibility complex class II levels allow
discrimination of WAM populations with distinct recruitment
patterns
Ly6c expression by macrophages as shown above could be
interpreted as a marker highlighting the exit from the inflam-
matory phase. Given the numerous potential roles described
for macrophages, a single-cell surface molecule appeared
unlikely to be sufficient to report such heterogeneity. Major
histocompatibility complex II (MHCII) is a commonly
expressed marker on monocytes and macrophages (Ingersoll
et al., 2010). In wounds, the expression of MHCII by WAMs
could vary 50-fold between MHCIIhi and MHCIIlo populations
on the basis of their mean fluorescence allowing a clear
discrimination of the high and low populations with no
intermediate levels (Figure 2a). The level of CD11c was
assessed in MHCIIhi and lo WAMs, and was similar in both
populations, significantly below what was observed in splenic
dendritic cells, suggesting that the MHCIIhi WAMs were not
dermal dendritic cells (Supplementary Figure 5 online). High
MHCII expression was observed on larger proportions of
WAMs along the healing course, from 24.5% (±1.2%) on
D1 to D40.2% (±3.5%) by D7 (P¼0.0002; Figure 2b).
When combined with Ly6c, four WAM populations with
distinct dynamics could be discriminated: the Ly6cloMHCIIlo
(LM ), the Ly6cloMHCIIhi (LMþ ), Ly6chiMHCIIlo
(LþM ), and the Ly6chiMHCIIhi (LþMþ ) (Figure 2c).
In the gt, as previously described in blood (Ingersoll et al.,
2010), MHCII expression was higher on Ly6clo cells (Supple-
mentary Figure 6 online). Among the Ly6chi WAMs, MHCIIlo
cells decreased massively between D1 and D2, whereas
MHCIIhi cells did not change in proportion over time from
D2 to D7 (Figure 2d; Supplementary Figure 6 online). This
indicated that the overall reduction of Ly6chi cells in the wound
concerned only the subpopulation of LþM cells. In the
Ly6clo compartment, the LM WAMs increased in propor-
tion between D1 and D2, and then remained constant, whereas
MP Rodero et al.
Il17lo Macrophages Promote Wound Healing
784 Journal of Investigative Dermatology (2013), Volume 133
the Ly6cloMHCIIhi (LMþ ) cell proportion increased progres-
sively all along the healing, explaining the general increase of
MHCII expression over time. Notably, only LMþ infiltration
in the gt positively correlated with wound surface reduction
(Pearson test, P¼ 0.037), suggesting an important role for this
population in the promotion of the wound closure (Figure 2e;
Supplementary Figure 8 online). Interestingly, the trend of
expression of MHCII by blood monocytes did not follow our
observations in wounds (Supplementary Figure 9 online),
suggesting that the variations observed in the gt resulted either
from events occurring during the extravasation process or in
response to the in situ environment. Overall, both Ly6c and
MHCII expression levels allowed the identification within the
WAMs of subpopulations with different infiltration kinetics.
Defective wound healing is associated with altered
LMþ macrophage infiltration
Our characterization suggested that the LMþ WAMs might
promote the healing, whereas other WAMs may be deleterious
regarding their association with wound size evolution.
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Figure 1. Monocyte/macrophage kinetics along skin wound healing. (a) Left: cytometry plot representation of wound infiltrating leukocytes based on CD11b
and Ly6g. (b) Percentage and (c) number of macrophages based on Ly6c expression level in the wound area at day 1 (D1) and D4 after wounding. (d) Left panels:
number of monocytes from D1 to D14 after wound healing in the wound, blood, and bone marrow from top to bottom. Middle panels: proportion of
Ly6chi and Ly6clo monocytes from D1 to D14 after wound healing in the wound, blood, and bone marrow from top to bottom. Right panels: number of
Ly6chi and Ly6clo monocytes from D1 to D14 after wound healing in the wound, blood, and bone marrow, from top to bottom. N¼ 3 to 6 mice depending
on time point. Results shown as mean±SD. WAM, wound-associated macrophage.
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To further assess this hypothesis, we analyzed WAM popula-
tions under pathological settings. Ob/Ob mice have a point
mutation that invalidates the leptin receptor. This model has a
systemic metabolic dysfunction resulting in obesity and
defective wound healing (Ansell et al, 2012). We compared
the proportions of monocyte and WAM subpopulations in WT
and Ob/Ob mice along wound healing (Figure 3). Both gt and
blood of Ob/Ob mice had higher numbers of monocyte/
macrophages compared with WT mice (data not shown). The
proportion of Ly6chi inflammatory monocytes was higher in
Ob/Ob mice wounds compared with WT controls (83±6 vs.
66±6, P¼0.007 at D1) (Figure 3a; Supplementary Figure 10
online), reflecting excessive inflammation in the context of
defective healing. This increased Ly6chi infiltration was
entirely due to LþM cells. Most strikingly, Ob/Ob mice
had significantly fewer LMþ WAMs at all time points
examined. The regular increase in the percentage of
Ly6cloMHCIIhi observed during normal healing could not be
retrieved in Ob/Ob mice (Figure 3b). Overall, these results
further emphasized the importance of the LMþ population,
suggesting that it could not exert its function in Ob/Ob mice.
This association was further validated through the demonstra-
tion of a significant reduction of LMþ WAMs at D4 in
Myd88KO mice, an alternative model of delayed wound
healing, when compared with WT controls (Supplementary
Figure 11 online; Macedo et al., 2007). This is particularly
significant as MyD88 mice did not display a reduction in the
total number of macrophages in wounds at D4 as compared
with WT controls.
LMþ wound macrophages are characterized by reduced
expression of inflammatory molecules
To further understand the potential functional differences
between the WAM populations described here, we analyzed
their gene expression profiles.
Although efforts have previously been made to characterize
‘‘in vitro activated macrophages’’ at the molecular level
(Mantovani et al., 2002; Pello et al., 2012), thorough in vivo
RNA array expression studies of macrophage heterogeneity
in mice are lacking. Hence, we FACS-sorted the LMþ
population for microarray analysis and compared it with
the LM or the LþMþ populations at D4 after
wounding, as at this time point all populations were
present in an environment switching from inflammation to
tissue repair.
We first confirmed that our sorted populations were over
98% pure. The RNA array results clearly validated this strategy
as the Ly6c gene, and MHC class II genes were differentially
expressed allowing us to easily identify each subpopulation
(Figure 4a). Clustering analyses showed strong associations
between the replicates from a same macrophage subpopula-
tion. This emphasized that at a global level each population
of WAMs had a different gene expression profile distinguishing
it from the other populations, and once again validated
the strategy of using Ly6c and MHCII expression levels to
distinguish macrophage populations within the wound.
Among the genes tested, 106 (110 probes) were significantly
differentially expressed between the WAM populations
(Supplementary Table 1 online). Genes involved in the
modulation of inflammation were differentially expressed
between macrophage populations, such as semaphorin 7a,
promoting inflammation (Suzuki et al., 2007), overexpressed
on LM cells or Tspan33, modulating the response to LPS
in LMþ macrophages (Suzuki et al., 2009). Besides, the
expression of NK lectin-type receptors with inhibitory (KLRi1)
or activating (KLrK1/NKG2D) motifs was another important
distinction between these populations (Burgess et al., 2008;
Saether et al., 2008). This clearly identified in vivo set of genes
that to our knowledge had never been previously associated
with macrophage polarization.
Previous studies have described the deleterious effect of
inflammation in wound healing as also observed in our obese
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Figure 2. Major histocompatibility complex II (MHCII) and Ly6c expression
levels define macrophage populations with distinct infiltration pattern
to the granulation tissue. (a) Histogram plot depicting the distribution of
macrophages based on MHCII expression level in the wound area at
day 1 (D1) and D4 after wounding. (b) Number of MHCIIhi and MHCIIlo
macrophages from D1 to D7 after wound healing. (c) Cytometry plot
representation of wound-associated macrophages (WAMs) based on
MHCII and Ly6c. (d) Proportion of each WAM population from D1 to 7.
(e) Correlation between wound closure representing reduction in wound
relative surface area and the proportion of LMþ macrophage population
(Pearson test, P¼0.037). (a, b) N¼6 to 12 mice depending on time point.
(d) N¼ 4 to 12 mice depending on time point. (e) N¼4 to 7 mice depending
on time point. Results shown as mean±SD.
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mice (Lai et al., 2009; Sindrilaru et al., 2011). Therefore, we
focused our expression studies on inflammatory mediators and
growth factors (Supplementary Table 3 online). Our analysis
revealed that the LMþ population had lower expression
of genes coding for inflammatory mediators, including
il12a, il17a, xcl1, ptges, Il17b, and Il24. This population also
expressed factors described to control inflammation and
promote wound closure such as ccl17 (Kato et al., 2011).
In contrast, the LM and the LþMþ WAMs had higher
expressions of inflammatory and proangiogenic markers, such
as alox15, Il4 or Il12, vegfa, or kallikrein. The most significant
inflammatory cytokine downregulated in LMþ
macrophages was Il17a (P¼0.047).
IL17 inhibits normal wound closure
IL17A (IL17) is a recently described cytokine having a major
role in many inflammatory and autoimmune disorders. It has
pleiotropic functions in the skin as exemplified in psoriasis,
given the widespread expression of its receptor on keratino-
cytes, fibroblasts, and most inflammatory cells (Martin et al.,
2012). In wounds on WT mice, il17a transcription within the
inflammatory infiltrate increased from D1 to D3, and decrea-
sed afterward suggesting a role in early stage inflammation of
the wound (Figure 4b). This paralleled the increased expres-
sion of other inflammatory cytokines, such as tnfa and il6 on
D1, but persisted longer. Indeed, both tnfa and il6 expressions
decreased rapidly from D2. ccl2 expression, often resulting
from monocyte/macrophage recruitment (Fantuzzi et al.,
1999), more closely followed il17a expression possibly
reflecting the importance of this cytokine in macrophage
activity in the wound.
Given our RNA array results, we were intrigued by the
presence of il17a in macrophages. The expression of IL17 by
myeloid cells, neutrophils, and macrophages has been pre-
viously reported (Song et al., 2008; Werner et al., 2011).
Double labeling of IL17 and F4/80 on wound sections clearly
showed the expression of IL17 by macrophages (Figure 4c)
with a decrease in the percentage of IL17þ macrophages at
D4 compared with D1 where IL17 was widely expressed
(Supplementary Figure 12 online). It is noteworthy that our
anti-IL17 antibody did not stain any cell in wounds from
IL17 / mice showing its specificity (data not shown). In
addition, using intracellular staining on flow cytometry, IL17
could not be retrieved among CD3þ cells as compared
with the CD11bþ population, further suggesting that
T cells were not the main source of IL17 in the skin
wounds (Supplementary Figure 13 online). To confirm that
IL17 was implicated in the control of wound healing, we
compared the wound closure between WT and IL17 /
mice. After 2 days, we observed a benefit in wound closure
of 20% with relative surface areas of the wound reported to
D0 at 84% (±29%) and 67% (±24%) (P¼0.024). As
wound healing in C57Bl/6 WT mice is not impaired,
this improvement in Il17 / mice during the early time
point is suggestive of a strong effect of IL17 inactivation
in wound healing promotion (Figure 5a). This accelerated
that wound closure in the IL17 / mice was associated
with an increase in the percentage of LMþ macrophages
at D2, supporting the role of this population in promoting
the difference observed in early stages of wound repair
(Figure 5b).
IL17 inhibition accelerates wound closure in Ob/Ob mice
Defective healing in Ob/Ob mice has been previously restored
by anti-inflammatory approaches, including tumor necrosis
factora inhibition or macrophage depletion (Goren et al.,
2007). At D3 after wounding, we observed an increased IL17
expression in Ob/Ob mice compared with WT using flow
cytometry (Figure 5c). In accordance with our results in WT
mice, IL17 expression was mostly restricted to the CD11bþ
cells and virtually absent from the CD11b cells. We next
used anti-IL17 blocking antibodies to restore the healing in
Ob/Ob mice. Mice were treated at days 0, 1, and 2 upon
wounding and wound closure was monitored during 10 days.
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We found that local delivery of IL17 blocking antibodies,
during the early stages of the healing for 3 consecutive days,
was sufficient to restore partially the wound closure for up
to 10 days, with significant differences between treated
and untreated wounds (Figure 5d). This benefit was at a
similar level as observed in previous reports using continuous
treatment with anti-tumor necrosis factor agents (Goren et al.,
2007).
DISCUSSION
In this study, we clearly demonstrate the in vivo heterogeneity
of macrophage populations recruited to the gt of full-thickness
excisional wounds. Using Ly6c and MHCII expression
levels, we distinguish subpopulations of macrophages with
different infiltration kinetics and distinct gene expression
profiles. Our results also established that the LMþ popula-
tion most likely promoted wound healing. Only LMþ cell
L–M– L–M+ L+M+
L–M– L–M+ L+M+
a
b
c
1 2 3 4 5
TNFa
0.00
0.25
0.50
0.75
1.00
–4.2 0 4.2
IL17
0.0
0.5
1.0
1.5
1 2 3 4 5
CCL2
0.0
0.5
1.0
1.5
1 2 3 4 5
IL6
0.00
0.25
0.50
0.75
1.00
1 2 3 4 5
Fo
ld
  D
1
F4/80 Il17 Merge
Cel
Nmnat2
Hnrpa3
Ctnnd2
Ctnnd2
Klri1
Map3k12
Ear10
Ly6c1
Chrdl1
EG432436
Hoxb3
Krba1
Klk1b27
D13Ertd608e
Pcdhgh8
V1rd2
Il17a
Gria1
Dennd5a
Cidec
Ash1l
Rnf182
Luzp2
1110008J03Rik
ENSMUSG00...
Tcam1
G6pc2
Mkx
Bnip3
OTTMUSG00...
Rps6kc1
Serpind1
Cep110
D330045A2...
Jmjd2d
D330045A2...
Syne1
EG241041
Ldhc
Sema7a
Klk1
Slc2a8
Slc22a4
2310045A20...
Mgl2
Alox5
4631427C17...
Ccnd1
Slarnf9
Mdm1
Gclm
Pltp
Mag
Tmem43
Rtel1
LOC100046...
Abhd12
Arntl
Ticam2
P2rx4
Snx6
Rabif
Mrpl13
Atp5c1
4930504E06...
Prr13
Bcl2l13
Hsd17b10
Uap1l1
Kcmf1
Spire1
Lrrc8
Gsg2
LOC100046...
Ptgs1
Nme4
Ccbl1
Folr2
Slco3a1
Hexim1
Csnk1e
Creb5
Ppp1r15b
Rnf183
Parp8
Gosr2
2210020M0...
H2-Eb1
H2-Ab1
H2-Ab1
H2-Aa
LOC641240
H2-DMa
Axl
Slamf8
Olfm1
Cd83
H2-Ob
Clec4b1
Cd209a
Clec4b1
Upb1
Tspan33
Adprhl1
Klrk1
1700008P20...
LOC381629
Cyb5d2
Adhfe1
LOC641240
H2-Aa
H2-Ab1
H2-Ab1
H2-Eb1
2210020M0...
Gosr2
Ly6c1
Chrdl1
EG432436
Hoxb3
Krba1
Klk1
Podhgb8
V1rd2
Klk1b27
D13Ertd608e
Il17a
Gria1
Dennd5a
Figure 4. Ly6c and major histocompatibility complex II (MHCII) distinguish wound-associated macrophage populations with distinct transcriptomic profiles.
(a) Clustering analysis of RNA expression levels from LM , LþMþ , and LMþ wound-associated macrophages. For convenience, only differentially
expressed genes are included in the figure (Po0.05; ANOVA with multiple testing correction) (b) RNA expression level as measured by real-time quantitative
reverse–transcriptase PCR of inflammatory cytokines in wound leukocytes over time. Plot representative of three independent experiments. Each point performed
on eight wounds from two mice. (c) Immunofluorescence staining of IL17 (green) and F4/80 (red) on wound sections. Photomicrographs depict the dermal
granulation tissue immediately beneath the wound surface at D1. TNFa, tumor necrosis factora. Bar¼ 20mm.
MP Rodero et al.
Il17lo Macrophages Promote Wound Healing
788 Journal of Investigative Dermatology (2013), Volume 133
proportion was associated with wound closure and this
population was most markedly reduced in different models
of delayed healing. This was further suggested by its gene
expression profile compared with other macrophage popula-
tions. Indeed, in LMþ cells, inflammatory mediators were
downregulated in favor of other transcripts promoting wound
healing. Finally, a key finding was the reduced expression of
il17 in LMþ distinguishing these macrophages from the
others. In accordance, the inhibition of IL17 clearly acceler-
ated normal and delayed wound closure, again arguing that
the LMþ population is most likely to promote the healing
of not only acute but also chronic wounds.
In our study, we established that in many aspects, monocyte
recruitment to the wound gt seems to follow trends already
established in other situations of acute injury, such as hind
limb or heart muscle ischemia, where Ly6chi cells infiltrate the
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tissue rapidly at the onset of injury to be followed by an
infiltration mainly composed of Ly6clo (Nahrendorf et al.,
2007; Cochain et al., 2010). Of interest, we also established
that many Ly6clo cells found in the wound area on D1 were
coming from the surrounding tissue.
In vivo studies have been proven difficult in assessing the
role and phenotype of macrophages. The observation of the
deleterious role of unrestricted proinflammatory macrophages
in generating chronic wounds introduced the concept of this
subgroup of macrophages as opposed to CD163-expressing
cells (Sindrilaru et al., 2011). In our study, we adopted an
unbiased approach in normal and delayed wound healing in
establishing macrophage subpopulations and presented very
consistent results. Indeed, in our model of delayed wound
healing in obese mice, we observed an over representation of
inflammatory LþM cells. This is in line with recent reports
of increased Ly6chi and reduced Ly6clo macrophage infil-
tration in Ob/Ob mice (Mirza and Koh, 2011). In addition to
these previously described populations, our labeling strategy
also outlined an LMþ population that seemed associated
with wound healing. It is noteworthy that despite expressing
high levels of MHCII, we believe this population does not
overlap with dermal dendritic cells, given its low expression
of CD11c. However, this does not exclude antigen
presentation capacity and T-cell priming as previously
reported (Martinez-Pomares and Gordon, 2012). All our
experiments were conducted in vivo where direct testing of
specific subpopulations is difficult. The small number of cells
did not allow us to conduct transfer experiments, and future
studies need to more precisely study the consequences of a
direct depletion of each population. However, we believe the
association of the LMþ population with wound closure
and its absence in defective healing in multiple situations
strongly support our claim that LMþ macrophages are key
in the repair phase of wound healing. These findings represent
a previously unreported insight into the wound healing
field. This unique opportunity to analyze macrophage
subpopulations during wound healing in vivo might reveal
previously unreported identifiers of the different macrophage
functions in vivo with more relevance than those of currently
used markers. This was the case for Semaphorin 7a or
some of the c-type lectin NK cell receptors. Taken together,
these data strongly support our initial hypothesis that different
subpopulations of macrophages with different and some-
times opposing functions could drive wound inflammation
or wound closure.
Our expression array analysis indicated that IL17 was the
most significant cytokine distinguishing inflammatory LM
and LþMþ from the LMþ population associated with
healing, prompting us to see its effect on wound closure. The
role of IL17 and its potential to affect skin biology has been
largely studied in the context of psoriasis, a chronic inflam-
matory skin disorder (Nograles and Krueger, 2011). How-
ever, its role in skin wound healing has never been described.
Our data provide evidence that IL17 is produced during the
early stages of wound healing. This is consistent with the
work from Chen et al. (2012), suggesting that IL17 initiated
early inflammation in a model of helminth-induced lung
inflammation. In their model, they also found better healing
after IL17 inhibition. Here we clearly establish by flow
cytometry and immunostaining that myeloid cells and more
specifically macrophages are a source of IL17 during the first
days of skin wound healing. IL17 inhibition in a genetic model
but also by neutralizing antibodies accelerated wound
healing, suggesting that the effect observed in IL17 /
animals compared with WT animals is not simply reflecting
major developmental changes in the knockout mice. These
findings clearly identify IL17 as a target to reduce wound
inflammation and initiate the repair process with potential
therapeutic benefits.
In summary, we describe a Ly6cloMHCIIhi subpopulation of
macrophages in wounds associated with wound closure.
Importantly, this macrophage population was missing in
defective wound healing. These Ly6cloMHCIIhi macrophages
had a noninflammatory transcriptomic profile and produced
chemokines that favored wound closure. Taken together, these
observations support that infiltration of the gt during healing
by noninflammatory macrophages supporting repair is a
critical step in successful wound repair. In particular, the
reduction of IL17 seems key in this transition as demonstrated
by improvement of the healing in normal and pathological
settings by IL17 inhibition. This highlights the potential of
anti-IL17 therapy in wound healing.
MATERIALS AND METHODS
Mice
Eight- to 12-week-old C57Bl/6J mice were purchased from the Animal
Resource Centre (Perth, WA, Australia). IL17 / and MyD88 /
have been previously described (Adachi et al., 1998; Nakae et al.,
2002). Ob/Ob mice were obtained from The Jackson Laboratory (Bar
Harbor, ME). All mice were used at 8–12 weeks of age. Equal ratios of
males and females were used in the experiments. All experiments
were conducted in conventional animal housing conditions in
accordance with ethical guidelines and approved by the University
of Queensland-Health Sciences Animal Ethics Committee.
Experimental wound preparation and analysis
Fourx full-thickness excisional wounds were generated down to the
panniculus carnosus with a 6-mm sterile punch (Stiefel Laboratories,
Research Triangle Park, NC). For IL17ab treatment, 30mg of IL17 ab
or control isotypes (R&D Systems, Mineapolis, MN) were injected
in the wound area at D0, D1, and D2 after wounding. Wound
evaluation was performed as previously described (Nassar et al.,
2012). All mice were treated in accordance with institutional ethics
approvals and guidelines for the care of experimental animals.
Tissue processing
Wounds were minced through a 70-mM cell strainer to generate
single-cell suspensions from wound gt. All cell suspensions were
layered on a Histopaque 1083 (Sigma Aldrich, St Louis, MO) for
gradient density centrifugation. The mononuclear cell fraction was
stained for flow cytometry analysis.
Flow cytometry
Dissociated single cells were pre-blocked with anti-CD16/CD32
(Becton Dickinson, San Jose, CA). Cell preparations were then
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incubated with either Rat anti-mouse CD11b PerCp-Cy5.5, MHCII
APC, MHCII FITC, Ly6g PE, NK1.1 PE, CD11c APC, Ly6c V450, F4/
80 Alexa647 for multiparameter flow acquisition and analysis.
For IL17 intracellular staining, cells were incubated for 4 hours with
Brefeldin A 1/1,000 (Biolegend, San Diego, CA) in DMEM. Cells were
harvested, stained with surface markers, fixed with 1% paraformal-
dehyde for 15 minutes at room temperature, permeabilized with
phosphate-buffered saline-saponin 0.1%, BSA 0.5%, EDTA 2 mM for
20 minutes at room temperature, and incubated with the proper Ab:
Rat Anti IL17 Alexa 647 (Biolegend).
A Gallios flow cytometer was used for sample acquisition, whereas
unbiased data analyses were performed using Kaluza analysis soft-
ware (Beckman Coulter, Miami, FL).
Immunohistochemistry
Dissected wounds were fixed with 4% paraformaldehyde and then
infused with 10% sucrose before cryoembedding and 7-mm cryo-
sections were obtained.
Staining was performed as previously described (Nassar et al.,
2012) with antibodies against F4/80 (Serotec, Oxford, UK) and IL17
(Proteintech Group, Chicago, IL). Images were captured using an LSM
710 confocal microscope (Carl Zeiss, Jena, Germany).
Generation of GFPþ BM chimeras
Five-week-old ptprc recipients were lethally irradiated with a total
dose of 1,000 cGy. BM was harvested from the long bones of
B6ROSAeGFP donors and a cell suspension containing 7 106
mononuclear cells was administered through retro-orbital injection
to irradiated recipients. After repopulation success was established,
dorsal excisional wounds were generated on GFPþ BM chimeras.
Reverse transcriptase–PCR analysis
Total RNA was extracted from Histopaque isolated wound leukocyte
using Qiagen micro kit (Qiagen, Hilden, Germany), according to the
manufacturer’s instructions. Total RNA was reverse transcribed to
cDNA using SupertScript Reverse Transcriptase (Invitrogen, Carlsbad,
CA). Real-time PCR was carried out using SYBR Premix (Invitrogen)
with specific primer sets (Supplementary Table 4 online). To standar-
dize mRNA concentrations, transcript levels of hprt were determined
in parallel for each sample, and relative transcript levels were
corrected by normalization on the basis of hprt transcript levels.
Microarray
Micro array protocol is detailed in Supplementary Material online.
Statistical analysis
All statistical analyses were performed using the GraphPad Prism v5c
software (San Diego, CA). Data were analyzed using the following
tests, Mann–Whitney (for nonparametric data), T-tests, one-way
analysis of variance (ANOVA), and two-way ANOVA with Bonferroni
adjustments for parametric distributions. Correlations were analyzed
by linear regression and R2 coefficient of determination was esta-
blished. Data were considered as parametric and a Pearson test
was conducted to show significance. A P-value less than 0.05 was
considered significant.
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